Epithelial-mesenchymal transition: a new target in anticancer drug discovery

Nature Reviews. Drug Discovery
Fabrizio MarcucciRuggero De Maria

Abstract

The conversion of cells with an epithelial phenotype into cells with a mesenchymal phenotype, referred to as epithelial-mesenchymal transition, is a critical process for embryonic development that also occurs in adult life, particularly during tumour progression. Tumour cells undergoing epithelial-mesenchymal transition acquire the capacity to disarm the body's antitumour defences, resist apoptosis and anticancer drugs, disseminate throughout the organism, and act as a reservoir that replenishes and expands the tumour cell population. Epithelial-mesenchymal transition is therefore becoming a target of prime interest for anticancer therapy. Here, we discuss the screening and classification of compounds that affect epithelial-mesenchymal transition, highlight some compounds of particular interest, and address issues related to their clinical application.

References

Mar 1, 1996·Clinical & Experimental Metastasis·R Martínez-ZaguilánM J Hendrix
Jun 19, 2001·Proceedings of the National Academy of Sciences of the United States of America·T BowmanR Jove
May 25, 2004·Genes & Development·Sonia VegaM Angela Nieto
Nov 19, 2004·Nature·Neil A BhowmickHarold L Moses
Dec 20, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert L YauchLukas C Amler
Apr 28, 2006·Nature·Janine T ErlerAmato J Giaccia
Jun 3, 2006·The Journal of Clinical Investigation·Martin JechlingerStefan Grünert
Dec 21, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·L Eric HuangAdrian L Harris
Mar 6, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Emilia FransveaGianluigi Giannelli
Mar 12, 2008·The Journal of Biological Chemistry·Kelly M Bailey, Jun Liu
Apr 23, 2008·Proceedings of the National Academy of Sciences of the United States of America·Cecilia SahlgrenUrban Lendahl
May 17, 2008·Cancer Research·Tamer T OnderRobert A Weinberg
Sep 23, 2008·Proceedings of the National Academy of Sciences of the United States of America·Nancy DumontThea D Tlsty
Feb 20, 2009·Molecular Biology of the Cell·Justin M DrakeMichael D Henry
Mar 6, 2009·Nature Reviews. Cancer·Kornelia Polyak, Robert A Weinberg
Jun 3, 2009·The Journal of Clinical Investigation·Raghu Kalluri
Aug 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·Chad J CreightonJenny C Chang
Sep 30, 2009·Nature Reviews. Clinical Oncology·Lori C KimEric B Haura
Oct 24, 2009·Nature Reviews. Cancer·Hua YuRichard Jove
Oct 31, 2009·International Journal of Cancer. Journal International Du Cancer·Angelo De MilitoStefano Fais
Dec 1, 2009·Cell·Jean Paul ThieryM Angela Nieto
Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Christine GjerdrumJames B Lorens
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Mei ZhangJeffrey M Rosen
Feb 11, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zhaojing ZhongYan Wu
Feb 23, 2010·Nature Cell Biology·Li MaRobert A Weinberg
Aug 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Joseph H TaubeSendurai A Mani

❮ Previous
Next ❯

Citations

Jun 1, 2016·Frontiers in Oncology·Fabrizio MarcucciFrançois Lefoulon
Oct 14, 2016·Cell Death & Disease·Ruby Yun-Ju Huang, Thomas Yo-Yan Huang
Mar 28, 2017·Acta Pharmacologica Sinica·Yan-Jing ZhuLei Chen
Jun 10, 2017·Molecular Oncology·Meggy Suarez-CarmonaChristine Gilles
Jun 8, 2017·Molecular Oncology·Patricia G SantamariaAmparo Cano
Jan 14, 2017·Molecular Oncology·Kay T Yeung, Jing Yang
Feb 22, 2018·Cancers·Joëlle Roche
Mar 9, 2018·International Journal of Cancer. Journal International Du Cancer·Claire AgostaNadia Cherradi
Mar 1, 2018·Journal of Dental Research·W ShangC Jiang
Aug 6, 2018·Journal of Cellular Physiology·Roghayyeh Vakili-GhartavolHamed Mirzaei
Aug 30, 2018·Lab on a Chip·Stephanie J Hachey, Christopher C W Hughes
Nov 6, 2018·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Jun NakanishiTakuji Nakashima
Jan 17, 2019·Archives of Pharmacal Research·Eunae Sandra ChoJong In Yook
Feb 10, 2019·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Haijun TianSamuel S Murray
May 22, 2019·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Angélica María HerreñoAdriana P Rojas
Oct 17, 2017·Laboratory Investigation; a Journal of Technical Methods and Pathology·Luca QuagliataLuigi M Terracciano
Jul 18, 2017·Oncogene·S M FrischP M Pifer
Oct 29, 2019·Journal of Cellular and Molecular Medicine·Rui CaoYe Tian
Oct 8, 2019·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Shota YamamotoJun Nakanishi
Oct 21, 2016·MedChemComm·Bibiana I FerreiraJames B Lorens
Dec 31, 2016·Oncotarget·Krystal D NolanJennifer S Isaacs
Sep 14, 2016·Oncotarget·Huifang TangGongda Xue

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis